Drugs that contain Fesoterodine Fumarate

1. List of Toviaz drug patents

TOVIAZ Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6858650 PFIZER Stable salts of novel derivatives of 3,3-diphenylpropylamines
Jul, 2022

(8 months ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6858650

(Pediatric)

PFIZER Stable salts of novel derivatives of 3,3-diphenylpropylamines
Jan, 2023

(2 months ago)

US8501723 PFIZER Pharmaceutical compositions comprising fesoterodine
Jun, 2027

(4 years from now)

US8088398 PFIZER Pharmaceutical compositions comprising fesoterodine
Jun, 2027

(4 years from now)

US7807715 PFIZER Pharmaceutical compositions comprising fesoterodine
Jun, 2027

(4 years from now)

US7807715

(Pediatric)

PFIZER Pharmaceutical compositions comprising fesoterodine
Dec, 2027

(4 years from now)

US8088398

(Pediatric)

PFIZER Pharmaceutical compositions comprising fesoterodine
Dec, 2027

(4 years from now)

US8501723

(Pediatric)

PFIZER Pharmaceutical compositions comprising fesoterodine
Dec, 2027

(4 years from now)

Exclusivity Exclusivity Expiration
New Indication (I) Jun 17, 2024
Pediatric Exclusivity (PED) Dec 17, 2024

Market Authorisation Date: 31 October, 2008

Treatment: Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of TOVIAZ before it's patent expiration?
More Information on Dosage

TOVIAZ family patents

6

United States

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic